Blood-test startups try to crawl out from the shadow of Theranos
As Daniel Levner tells it, the “Theranos effect” came in three distinct waves. First, he says, when the company was at its peak, many investors wouldn’t bother funding other blood-testing startups, because how could anyone compete with the youngest, female, self-made billionaire? Then, as news brok...
Best Children's Hospitals US - / Boston Children's Hospital - 2 hours from now
